Co-activators and co-repressors: mediators of gene activation by nuclear hormone receptors

[10 years of lipodystrophy--and so many uncertainties].

Revue medicale suisse·2009

Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus.

Diabetes & metabolism·2008

[Endocrinology].

Revue medicale suisse·2006

Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.

Alimentary pharmacology & therapeutics·2006

Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.

Diabetologia·2005

[Growth hormone treatment: pediatric to adult clinic transition].

Revue medicale suisse·2005

BMI as a partitioning factor for estradiol and estrone reference intervals in middle-aged men and postmenopausal women.

European journal of endocrinology·2026

Machine learning quantifies within-subject facial change in acromegaly.

European journal of endocrinology·2026

Carbonyl Reductase 1 regulates prednisolone clearance and modifies its adverse effect profile.

European journal of endocrinology·2026

Diagnostic Utility of Diurnal Salivary Cortisol Profiles in Neoplastic and Non-Neoplastic Hypercortisolism.

European journal of endocrinology·2026

When to stop monitoring pituitary stalk thickening?

European journal of endocrinology·2026

A Genetic Risk Approach to Differential Diagnosis of Type 1 Diabetes and Risk Stratification in the Spanish Population.

European journal of endocrinology·2026

Triple Genetic Alterations (EGFR Mutation, ALK Fusion, and MET Polysomy) in Gynecological Metastasis of Lung Adenocarcinoma Patient with Acquired Resistance to Furmonertinib: A Case Report.

Current oncology (Toronto, Ont.)·2026

Up-Front Immune Checkpoint Inhibitors in Patients with Multiple Synchronous Primary Tumors, Including dMMR/MSI-H Gastrointestinal Malignancies: A Case Series and Review of the Literature.

Current oncology (Toronto, Ont.)·2026

Advanced Therapies for Diabetic Kidney Disease: A Critical Review of Gene-, RNA-, and Cell-Based Strategies to Address Residual Risk.

Diseases (Basel, Switzerland)·2026

Association of DNA Copy Number Aberrations with Organ-Specific Metastasis in Luminal B HER2-Negative Breast Cancer.

Diseases (Basel, Switzerland)·2026

Carboxymethylcellulose/Hyaluronic Acid Hybrid Nanoconjugates: Toward Multifunctional Platforms for Melanoma Skin Cancer Theranostics.

Gels (Basel, Switzerland)·2026

Antagonistic TGR5 and FXR Signaling Shapes STAT1-Dependent Interferon Responses in Intestinal Epithelial Cells.

Cells·2026

Related Experiment Videos

Co-activators and co-repressors: mediators of gene activation by nuclear hormone receptors

Related Concept Videos

[10 years of lipodystrophy--and so many uncertainties].

Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus.

[Endocrinology].

Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.

Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.

[Growth hormone treatment: pediatric to adult clinic transition].

BMI as a partitioning factor for estradiol and estrone reference intervals in middle-aged men and postmenopausal women.

Machine learning quantifies within-subject facial change in acromegaly.

Carbonyl Reductase 1 regulates prednisolone clearance and modifies its adverse effect profile.

Diagnostic Utility of Diurnal Salivary Cortisol Profiles in Neoplastic and Non-Neoplastic Hypercortisolism.

When to stop monitoring pituitary stalk thickening?

A Genetic Risk Approach to Differential Diagnosis of Type 1 Diabetes and Risk Stratification in the Spanish Population.

Triple Genetic Alterations (EGFR Mutation, ALK Fusion, and MET Polysomy) in Gynecological Metastasis of Lung Adenocarcinoma Patient with Acquired Resistance to Furmonertinib: A Case Report.

Up-Front Immune Checkpoint Inhibitors in Patients with Multiple Synchronous Primary Tumors, Including dMMR/MSI-H Gastrointestinal Malignancies: A Case Series and Review of the Literature.

Advanced Therapies for Diabetic Kidney Disease: A Critical Review of Gene-, RNA-, and Cell-Based Strategies to Address Residual Risk.

Association of DNA Copy Number Aberrations with Organ-Specific Metastasis in Luminal B HER2-Negative Breast Cancer.

Carboxymethylcellulose/Hyaluronic Acid Hybrid Nanoconjugates: Toward Multifunctional Platforms for Melanoma Skin Cancer Theranostics.

Antagonistic TGR5 and FXR Signaling Shapes STAT1-Dependent Interferon Responses in Intestinal Epithelial Cells.

Related Experiment Videos

Co-activators and co-repressors: mediators of gene activation by nuclear hormone receptors

Related Concept Videos

Related Articles